The revenue stands at ₹15,299.88 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.71 per cent from ₹14,611.79 crore. This corresponds to a year-on-year *(YoY) growth of 10.46 per cent.
Operating Profit stands at ₹4,213.58 crore, reflecting a quarter-on-quarter *(QoQ) increase of 6.56 per cent from ₹3,954.20 crore. This corresponds to a year-on-year *(YoY) growth of 20.95 per cent.
PBDT stands at ₹4,827.96 crore, reflecting a quarter-on-quarter *(QoQ) increase of 11.95 per cent from ₹4,312.75 crore. This corresponds to a year-on-year *(YoY) growth of 24.96 per cent.
Profit Before Tax stands at ₹4,089.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 15.60 per cent from ₹3,537.28 crore. This corresponds to a year-on-year *(YoY) growth of 29.28 per cent.
Net Profit stands at ₹2,901.23 crore, reflecting a quarter-on-quarter *(QoQ) increase of 7.07 per cent from ₹2,709.66 crore. This represents a 26.53 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | -1.98% | -2.00% | 1.93% | 7.10% | 14.55% | 19.47% |
| Divi's Lab. | 3.30% | 6.79% | 21.49% | 25.10% | 35.63% | 29.85% |
| Torrent Pharma. | -1.64% | 2.90% | 4.06% | 17.38% | 26.33% | 39.84% |
| Cipla | -0.27% | -0.30% | -0.15% | 10.16% | 10.23% | -2.02% |
Chairman / Executive Director / M D / Promoter : Dilip S Shanghvi
Executive Director & MD : Kirti Wardhaman Ganorkar
Lead Independent Non Executive Director : Pawan Goenka
Independent Non Exe. Director : Gautam Doshi
Independent Non Exe. Director : Rolf Hoffmann
ED / WTD / CFO / Promoter : AALOK DILIP SHANGHVI
E D & Wholetime Director : Vidhi Shanghvi
Independent Non Exe. Director : Satyavati Berera
Independent Non Exe. Director : Andreas Busch
Company Sec. & Compli. Officer : ANOOP ANJANIKUMAR DESHPANDE